Jointown Pharmaceutical Group (600998.SH): The Drug Registration Certificate for Promethazine Hydrochloride Injection is obtained.

Jointown Pharmaceutical Group (600998.SH) announced that on December 25, 2025, its subsidiary Beijing Jingfeng Pharmaceutical Group Co., Ltd. (referred to as "Jingfeng Pharmaceutical") subsidiary, Huiyu Yuanhe (Hainan) Pharmaceutical Co., Ltd. (referred to as "Huiyu Yuanhe"), has received the drug registration certificate issued by the National Medical Products Administration for the hydrochloride metoclopramide injection. Hydrochloride metoclopramide injection is an anti-histamine drug used for allergic reactions of the skin and mucosa, motion sickness, as an adjunct treatment for anesthesia and before and after surgery, and for the prevention and treatment of radiation-induced or drug-induced nausea and vomiting.